Page last updated: 2024-09-04

n(6)-benzyl-cyclic adenosine 5'-monophosphate and Cancer of Prostate

n(6)-benzyl-cyclic adenosine 5'-monophosphate has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Misra, UK; Pizzo, SV1

Other Studies

1 other study(ies) available for n(6)-benzyl-cyclic adenosine 5'-monophosphate and Cancer of Prostate

ArticleYear
Upregulation of mTORC2 activation by the selective agonist of EPAC, 8-CPT-2Me-cAMP, in prostate cancer cells: assembly of a multiprotein signaling complex.
    Journal of cellular biochemistry, 2012, Volume: 113, Issue:5

    Topics: Adaptor Proteins, Signal Transducing; Carrier Proteins; Cell Line, Tumor; Chromones; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Endoplasmic Reticulum Chaperone BiP; Gene Silencing; Guanine Nucleotide Exchange Factors; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Models, Biological; Morpholines; Multiprotein Complexes; Phosphorylation; Prostatic Neoplasms; Protein Multimerization; Proteins; Proto-Oncogene Proteins c-akt; Rapamycin-Insensitive Companion of mTOR Protein; Regulatory-Associated Protein of mTOR; Ribosomal Protein S6 Kinases; RNA-Binding Proteins; Signal Transduction; Sirolimus; Thionucleotides; TOR Serine-Threonine Kinases; Up-Regulation

2012